Abstract
Alzheimer's disease (AD) is an age-related progressive neurodegenerative disease, which is characterized clinically by serious impairment in memory and cognition. Current medications only slow down the dementia progression and the present treatment one-drug one-target paradigm for anti-AD treatment appears to be clinically unsuccessful. Therefore, alternative therapeutic strategies are urgently needed. With respect to multifunctional and multitargeted characteristics of Rosa damascena via its effective flavonoids, we investigated the effects of R. damascena extract on behavioral functions in a rat model of amyloid-β (A-β)-induced Alzheimer's disease. After preparation of the methanolic extract of the R. damascena, HPLC analysis and toxicity studies, median lethal dose (LD50) and dose levels were determined. For evaluation of baseline training behavioral performance, Morris water maze and passive avoidance tests were used. A-β was injected bilaterally into CA1 area of the hippocampus. Twenty-one days after injection of A-β, the first probe trial of the behavioral tests were used to confirm learning and memory impairment. To examine the potential effects of the extract on behavioral tasks, the second probe trials were performed a...Continue Reading
Citations
Feb 11, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Arman ZargaranAbdolali Mohagheghzadeh
Oct 30, 2016·Regulatory Toxicology and Pharmacology : RTP·Galina NikolovaVeselina Gadjeva
Sep 20, 2016·Neuropeptides·Sahreh ShabaniYaghoob Farbood
Jan 11, 2017·Scientific Reports·Houyou YuWen Yin
Aug 24, 2017·Pharmaceutical Biology·Arezoo Rezvani-KamranAlireza Komaki
Jul 13, 2019·Experimental Physiology·Marjan ErfaniAva Nasrolahi
Mar 2, 2019·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Mohammad KarimipourHesam Saghaei Bagheri
Apr 21, 2020·Phytotherapy Research : PTR·Adrian L LoprestiPeter D Drummond
Mar 19, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Yan LiuXiling Wu
Mar 27, 2020·The Journal of Physiological Sciences : JPS·Ghazaleh OmidiAlireza Komaki
Jan 27, 2017·Metabolic Brain Disease·Yaghoob FarboodLayasadat Khorsandi
Jun 8, 2017·International Journal of Molecular Sciences·Inés MármolMaría Jesús Rodríguez-Yoldi
Jan 23, 2018·PloS One·Zahra SerajAtiyeh Ghasemi
Feb 26, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kristina Endres
May 4, 2017·Molecular Neurobiology·Karim A Alkadhi
Jul 12, 2020·Journal of Alzheimer's Disease : JAD·Camila CalfioRicardo B Maccioni
Dec 10, 2019·Neuroscience Letters·Abhishek SinghSarika Singh
Nov 24, 2020·Frontiers in Molecular Neuroscience·Beatriz Calvo-Flores GuzmánAndrea Kwakowsky
May 1, 2021·The Journal of Physiological Sciences : JPS·Seyed Asaad KarimiAlireza Komaki
Sep 5, 2020·ACS Chemical Neuroscience·Hoda EskandariDaniel E Otzen
Apr 22, 2021·CNS & Neurological Disorders Drug Targets·Himanshi Varshney, Yasir Hasan Siddique